Related references
Note: Only part of the references are listed.Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
Hakon Blomstrand et al.
BMC CANCER (2019)
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2
Teresa Macarulla et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine plus /- nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)
Johannes Betge et al.
BMC CANCER (2018)
Five Cases of Interstitial Pneumonitis Due to Gemcitabine and Nab-Paclitaxel Combination Treatment in Pancreatic Cancer Patients
Yusuke Ogawa et al.
PANCREAS (2018)
Combination therapy versus gemcitabine monotherapy in the treatment of elderly pancreatic cancer: a meta-analysis of randomized controlled trials
Jiamin Jin et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer
Hideki Ueno et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Clinical outcome of elderly patients with unresectable pancreatic cancer treated with gemcitabine plus S-1, S-1 alone, or gemcitabine alone: Subgroup analysis of a randomised phase III trial, GEST study.
Hiroshi Imaoka et al.
EUROPEAN JOURNAL OF CANCER (2016)
Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults
Yuhei Hamaguchi et al.
NUTRITION (2016)
Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial
Werner Scheithauer et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project
Megumi Hori et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
Hideki Ueno et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
EORTC elderly task force position paper: Approach to the older cancer patient
A. G. Pallis et al.
EUROPEAN JOURNAL OF CANCER (2010)
Share Paper
